Inflammation in asthma: the cornerstone of the disease and target of therapy.
暂无分享,去创建一个
[1] K. Chung,et al. Cytokines in asthma , 1999, Thorax.
[2] S. Holgate. The rising trends in asthma , 1997 .
[3] C. Bachert,et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. , 1997, Journal of immunology.
[4] A. Leff,et al. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. , 1997, American journal of respiratory and critical care medicine.
[5] S. Peters,et al. Kinetics of the development and recovery of the lung from IgE-mediated inflammation: dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines. , 1997, American journal of respiratory and critical care medicine.
[6] S. Mann,et al. Ciba Foundation Symposium , 1997 .
[7] S. Holgate. Asthma: a dynamic disease of inflammation and repair. , 1997, Ciba Foundation symposium.
[8] D. Underwood,et al. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. , 1996, American journal of respiratory and critical care medicine.
[9] D. Sampath,et al. The one-two of T helper cells: does interferon-gamma knock out the Th2 hypothesis for asthma? , 1996, American journal of respiratory cell and molecular biology.
[10] C. Page,et al. Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. , 1996, The European respiratory journal.
[11] J. Drazen,et al. Sorting out the cytokines of asthma , 1996, The Journal of experimental medicine.
[12] D. Yates,et al. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. , 1996, American journal of respiratory and critical care medicine.
[13] S. Wenzel,et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. , 1995, American journal of respiratory and critical care medicine.
[14] P. Howarth,et al. Heterogeneity of human mast cells based on cytokine content. , 1995, Journal of immunology.
[15] K. Chung,et al. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. , 1995, American journal of respiratory and critical care medicine.
[16] D. James,et al. Are you TH‐l or TH‐2? , 1995 .
[17] T. Schall,et al. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. , 1995, American journal of respiratory cell and molecular biology.
[18] P. Barnes,et al. Nitric oxide and asthmatic inflammation. , 1995, Immunology today.
[19] P. O'Byrne,et al. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. , 1994, American journal of respiratory cell and molecular biology.
[20] P. Barnes,et al. Cytokines as mediators of chronic asthma. , 1994, American journal of respiratory and critical care medicine.
[21] S. Spector,et al. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. , 1994, American journal of respiratory and critical care medicine.
[22] M. Calderón,et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. , 1994, American journal of respiratory and critical care medicine.
[23] C. Page,et al. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.
[24] I. Adcock,et al. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. , 1994, Immunology.
[25] D. Postma,et al. Early and late asthmatic reaction after allergen challenge. , 1994, Respiratory medicine.
[26] W. Busse,et al. The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma , 1993, Annals of Internal Medicine.
[27] T. Takishima,et al. The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects. , 1993, The Journal of allergy and clinical immunology.
[28] P. Barnes,et al. Nitric oxide and lung disease. , 1993, Thorax.
[29] S. Durham,et al. Cytokines. 3. Cytokines in asthma. , 1993, Thorax.
[30] A. Sousa,et al. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. , 1993, The American review of respiratory disease.
[31] T. Haahtela,et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways , 1993, The Lancet.
[32] K. Chung,et al. Effect of inhaled corticosteroids on peripheral blood eosinophil counts and density profiles in asthma. , 1993, The Journal of allergy and clinical immunology.
[33] W. Timens,et al. Bronchial lavage and bronchoalveolar lavage in allergen-induced single early and dual asthmatic responders. , 1993, The American review of respiratory disease.
[34] D. Margolskee,et al. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma. , 1992, The Journal of allergy and clinical immunology.
[35] P. Jeffery,et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. , 1992, The American review of respiratory disease.
[36] P. Howarth,et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. , 1992, The American review of respiratory disease.
[37] B. Schmekel,et al. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. , 1992, The European respiratory journal.
[38] S. Romagnani. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? , 1992, Immunology today.
[39] W. Busse,et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. , 1991, The American review of respiratory disease.
[40] H. Kita,et al. Glucocorticoids inhibit cytokine-mediated eosinophil survival. , 1991, Journal of immunology.
[41] W. Roche. Fibroblasts and asthma , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[42] R. Schleimer,et al. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. , 1991, Journal of immunology.
[43] Paul H. Rubin,et al. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. , 1991, Thorax.
[44] S. Wenzel,et al. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. , 1991, The Journal of allergy and clinical immunology.
[45] H. Kita,et al. Effect of steroids on immunoglobulin-induced eosinophil degranulation. , 1991, The Journal of allergy and clinical immunology.
[46] E. R. Mcfadden,et al. Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. , 1991, Annals of allergy.
[47] S. Moncada,et al. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[48] S. Moncada,et al. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. , 1990, Biochemical and biophysical research communications.
[49] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[50] S. Wenzel,et al. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. , 1990, The American review of respiratory disease.
[51] P. Bruijnzeel,et al. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate , 1990, British journal of pharmacology.
[52] P. Sterk,et al. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. , 1990, The American review of respiratory disease.
[53] R. Miesfeld. Molecular genetics of corticosteroid action. , 1990, The American review of respiratory disease.
[54] A. Wardlaw,et al. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. , 1989, The American review of respiratory disease.
[55] L. Lichtenstein,et al. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. , 1989, The American review of respiratory disease.
[56] L. Frølund,et al. A comparison of the effects of nedocromil sodium and beclomethasone dipropionate on pulmonary function, symptoms, and bronchial responsiveness in patients with asthma. , 1989, The Journal of allergy and clinical immunology.
[57] O. Burghuber,et al. Long-term treatment with disodium cromoglycate does not alter bronchial hyperreactivity in patients with perennial bronchial asthma. , 1989, Respiration; international review of thoracic diseases.
[58] N. Thomson. Nedocromil sodium: an overview. , 1989, Respiratory medicine.
[59] S. Holgate,et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.
[60] P. Bruijnzeel,et al. Nedocromil sodium inhibits the A23187‐ and opsonized zymosan‐induced leukotriene formation by human eosinophils but not by human neutrophils , 1989, British journal of pharmacology.
[61] R. Stenling,et al. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. , 1988, The European respiratory journal.
[62] S. Wenzel,et al. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. , 1988, The American review of respiratory disease.
[63] P. O'Byrne,et al. Late asthmatic responses. , 1987, The American review of respiratory disease.
[64] P. O'Byrne,et al. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. , 1987, The American review of respiratory disease.
[65] A. Kay,et al. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. , 1987, The Journal of allergy and clinical immunology.
[66] S. Wasserman,et al. Cromolyn inhibition of mediator release in mast cells derived from mouse bone marrow. , 1986, The American review of respiratory disease.
[67] R. Coffman,et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.
[68] N. Johnson,et al. Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate. , 1985, Clinical science.
[69] A. B. Kay,et al. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. , 1984, The Journal of allergy and clinical immunology.
[70] A. Kay,et al. Preferential generation of leukotriene C4 by human eosinophils. , 1984, Clinical and experimental immunology.
[71] L. A. Cupples,et al. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. , 1983, The American journal of medicine.
[72] S. Peters,et al. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. , 1983, The Journal of clinical investigation.
[73] M. Church,et al. The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine , 1983, British journal of pharmacology.
[74] J. Gauldie,et al. Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. , 1982, Journal of immunology.
[75] J. Anderson,et al. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema , 1969, Thorax.
[76] M. Dunnill. THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA , 1960, Journal of clinical pathology.